Immatics NV (IMTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $939.49M
Last updated: Nov 17, 2026 at 4:33 PM ET
Immatics NV (IMTX) Statistics
Immatics NV (IMTX) has a market cap of $939.49M. It kept -534.13% of revenue as net income over the last 12 months. Its share count is up 18.67% from a year earlier.
Total Valuation
| Market Cap | $939.49M |
|---|---|
| Latest price (Nov 17, 2026) | $6.29 |
Key Dates
The next earnings report is expected on Mar 3, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 3, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 10, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 18.0x and 1.8x. Its year-end P/S ranged from 1.5x to 23.6x from 2020 to 2025.
| P/S Ratio | 18.0x |
|---|---|
| P/B Ratio | 1.8x |
| P/TBV Ratio | 1.8x |
Price Statistics
The stock is down 38.33% over 52 weeks and trades 17.02% below its 50-day average.
| Beta (1Y) | 1.45 |
|---|---|
| 52-Week Change | -38.33% |
| 1-Month Change | -10.78% |
| 3-Month Change | -32.00% |
| 6-Month Change | -41.22% |
| 5-Year Change | -49.76% |
| Total Return (1Y) | -38.33% |
| Total Return (3Y CAGR) | -10.18% |
| Total Return (5Y CAGR) | -12.37% |
| Return vs SPY (1Y) | -50.61% |
| Max Drawdown (1Y) | -48.02% |
| Max Drawdown (3Y) | -74.05% |
| Sharpe Ratio (1Y) | -0.91 |
| Correlation with SPY (1Y) | 0.37 |
| 50-Day Average | $7.58 |
| 200-Day Average | $9.39 |
| 52-Week Range | $6.07 to $12.41 |
| RSI (14 Days) | 36.2 |
| Average Volume (20 Days) | 1.17M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 5.03x current liabilities.
| Current Ratio | 5.03x |
|---|---|
| Quick Ratio | 5.03x |
| Interest Coverage | 25.09x |
Returns and Efficiency
Return on equity is -53.59% over the last 12 months, against a 5-year average of -91.14%.
| Return on Equity (ROE) | -53.59% |
|---|---|
| Return on Assets (ROA) | -41.54% |
| Return on Capital Employed (ROCE) | -49.93% |
| ROE (5Y Average) | -91.14% |
| ROA (5Y Average) | -19.59% |
| ROIC (5Y Average) | -82.54% |
| Asset Turnover | 0.08x |
| Receivables Turnover | 3.02x |
Scores
IMTX has an Altman Z-Score of 0.92, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 0.92 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 2 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue of EUR 43.44M over the last 12 months is down 48.75% from the 12 months before.
| Revenue | EUR 43.44M |
|---|---|
| Revenue Growth (YoY) | -48.75% |
| Gross Profit | EUR 43.44M |
| Operating Income | EUR -250.69M |
| Pretax Income | EUR -232.52M |
| Net Income | EUR -232.03M |
| EBITDA | EUR -219.81M |
| EBIT | EUR -231.68M |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 77.51% of the EUR 565.72M in total assets.
| Working Capital | EUR 409.27M |
|---|---|
| Shareholder Equity | EUR 438.50M |
| Tangible Book Value | EUR 436.84M |
| Total Assets | EUR 565.72M |
| Total Liabilities | EUR 127.22M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | EUR -222.27M |
|---|---|
| Depreciation and Amortization | EUR 11.87M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -577.10%.
| Gross Margin | 100.00% |
|---|---|
| Operating Margin | -577.10% |
| Pretax Margin | -535.27% |
| Net Margin | -534.13% |
| EBITDA Margin | -506.01% |
| EBIT Margin | -533.34% |
Growth
Revenue fell 34.64% a year over 3 years.
| Revenue Growth (3Y CAGR) | -34.64% |
|---|---|
| Revenue Growth (5Y CAGR) | +9.08% |
Peer Position
Against 7 similar companies, IMTX has the 4th highest P/S.
P/S RatioPeer median 8.4x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -61.33%
| P/S Ratio | 18.0x vs 8.4x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -48.75% vs -61.33% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About IMTX
What is IMTX's market cap?
Immatics NV has a market cap of $939.49M.
How many shares of IMTX are outstanding?
Immatics NV has 144.26M shares outstanding. The count is up 18.67% from a year earlier.
Does IMTX pay a dividend?
No. Immatics NV does not pay a dividend.
IMTX pages: Overview, Charting, Financials, Statistics, Valuation, Competitors